Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
Johanne Tremblay, Yujia Wang, John Raelson, Francois-Christophe Marois-Blanchet, Zenghui Wu, Hongyu Luo, Edward Bradley, John Chalmers, Mark Woodward, Stephen Harrap, Pavel Hamet, Jiangping Wu
Scientific Reports | NATURE PUBLISHING GROUP | Published : 2017
Awarded by Canadian Institutes of Health Research
Awarded by Natural Sciences and Engineering Research Council of Canada
Awarded by Juvenile Diabetes Research Foundation
Awarded by Fonds de recherche du Quebec-Sante
The authors thank Jerry Pelletier (Biochemistry, McGill) for help in analyzing RNA motifs in the 3' UTR of EFNB3. This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP57697, MOP69089 and MOP 123389), H.L. (MOP97829), JT and P.H (ISO106797). It was also financed by grants from the Natural Sciences and Engineering Research Council of Canada (203906-2012), Juvenile Diabetes Research Foundation (17-2013-440), Fonds de recherche du Quebec-Sante (Ag-06) and the J.-Louis Levesque Foundation to J.W. It is financed also by grants from OPTI-THERA to J.T. and P.H.